VKTX: Double Bottom detected on 11 Nov 2026

All prices, scores, and news on this page reflect data available before market open on .

Free example: 1 of 51 setups from the 11 Nov 2026 scan. Subscribers get the full list every trading day by 6 AM ET.

On 11 Nov 2026, our scan flagged VKTX as a double bottom setup scoring 72 out of 98 (Good tier), with a 68% win probability based on our historical pattern database and a 0.35 to 1 risk to reward profile from the published levels. This is a swing trade setup: win probability reflects a multi-day swing hold, not an intraday move. At $28.66, the conservative target is $30.08 with a stop at $24.60. A further breakout above resistance near $43.10 offers a larger move if momentum continues past the initial target.

72 of 98
Good
68%
Moderate
0.35 : 1
$1.42 to target $4.06 to stop
Swing Trading Plan
Entry
$28.66
$30.08
$24.60
2-8 trading days
Exp. Reward
+$0.76
Exp. Risk
-$0.61

Expected figures are probability-weighted from our historical pattern database; Trade R:R is measured from the entry, target and stop levels.

Current Setup
VKTX forms a double-bottom pattern with structure score 14.06 and volume score 12.0, indicating a solid base formation. The pattern shows a current price of $28.66 positioned between key support at $23.82 and key resistance at $43.10. Breakout score of 10.83 suggests moderate confirmation capability. Technical indicators show RSI at 53.43 (neutral, not overbought), positive MACD histogram at 0.4933 supporting upside momentum, and the stock trades at 20.32% above its 52-week low after a 9.85% gain in one week and 15.15% in two weeks. Volume remains near average at 0.95x relative volume, with ATR at 1.71 (5.97% volatility), indicating controlled risk parameters.
Stock Context
Viking reported a wider-than-expected third-quarter loss as spending accelerated across its obesity pipeline, while its late-stage trials remain on track and cash balance rose to $960 million. The company posted a loss of $1.55 per share against analyst expectations of $1.06. However, pipeline catalysts are mounting: Viking will present two VK2735 posters at ObesityWeek November 14-17, 2026 in Washington D.C., covering Phase 3 VANQUISH-2 study baseline characteristics and obesity severity/cardiometabolic parameters from Phase 2 VENTURE. UBS recently initiated coverage with a Buy rating and $94 price target. Recent analyst actions include a Barclays upgrade in mid-October and Canaccord maintaining Buy. The near-term conference presentations provide newsflow support for this technical setup, while the sector regimes bullish stance (0.82) contrasts sharply with broader market bearish tone (-0.54).
What to Expect
A successful double-bottom breakout would target the conservative price level of $30.08, representing 4.95% upside from current levels. The pattern setup suggests a 67.93% historical win probability based on comparable structures. Volume confirmation would need to exceed current relative volume levels during a sustained breakout above the $30 zone toward resistance at $43.10. The invalidation level sits at key support of $23.82—a break below this level would negate the setup and signal a pattern failure. Given the moderate breakout score of 10.83, initial confirmation requires price holding above $30 with expanding volume into the $30.50-$31.50 zone to gain conviction for a full measured move toward $43.10.
Risk Factors
Q3 earnings miss on October 28 sparked initial selling despite pipeline progress, creating headline risk around earnings surprises going forward. The company is spending heavily as it moves obesity programs through late-stage testing and prepares for possible commercial launch, with accelerating R&D spending. Clinical trial execution risk remains material—any negative VK2735 data presented at ObesityWeek (Nov 14-17) could reverse this pattern setup sharply. The stock's 0.77 beta suggests lower volatility than market, but biotech clinical-stage risk is concentrated; unfavorable efficacy or safety findings would trigger deep drawdowns. The company raised $575 million through dilutive equity/convertible offerings in September, which may weigh sentiment. Monitor cash burn rate relative to the $960M runway and watch for any regulatory pathway delays in obesity drug approvals.
How We Find and Score This Setup
We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading. What the terms mean →
Frequently Asked Questions
Is VKTX a good swing trade?
VKTX scored 72 out of 98 on our double bottom scan, with a 68% historical win probability over a 2-8 trading days hold. Good setup based on our systematic scoring.
What is the entry, target, and stop loss for this setup?
The setup's reference price is $28.66, with a conservative target of $30.08 and a stop loss at $24.60.
What would invalidate this double bottom setup?
A close below the stop loss at $24.60 would invalidate the setup and suggest the pattern has failed.
How is the win probability calculated?
Win probability is a calibrated estimate of how similar historical double bottom setups performed over the following 10 trading days, drawn from a database of 370,000+ historical pattern detections across 6,000+ NYSE and NASDAQ stocks.
Market & Sector Regime
Market
Bearish -0.54
-1.0 0 +1.0
Health Care Sector
Bullish 0.82
-1.0 0 +1.0
Overall Score
37 of 40
Exceptional
Pattern Quality
14 of 20
Good
Setup
11 of 20
Fair
R/R
10 of 18
Fair
Context
Pattern Quality Score
14 of 15
Exceptional
Structure
11 of 13
Strong
Breakout
12 of 12
Exceptional
Volume
Recent Performance
+9.8%
1W
+15.2%
2W
+1.1%
1M
-15.8%
3M
Momentum & Trend
RSI (14)
53.4
Neutral
MACD Histogram
+0.49
Bullish
Bollinger Band Position
94.2%
Upper Band
Volatility & Risk
20-Day Volatility
0.79
Very High
ATR %
6.0%
High
Beta
0.77
Below Mkt
Volume Analysis
Volume Ratio
0.95x
Average
20-Day Avg Vol
4.5M
shares / day
Current Volume
4.3M
shares traded
Price Levels
52W High
$43.15
Resistance
$43.10
Target
$30.08
Current
$28.66
Stop Loss
$24.60
Support
$23.82
52W Low
$23.82
Disclaimer: This analysis is algorithmically generated for educational purposes only and does not constitute financial advice. Past pattern performance does not guarantee future results. Win probabilities are based on historical data across 370,000+ observations. Always conduct your own research and consult a qualified financial advisor. AI-assisted contextual analysis by Claude (Anthropic). Indicators reflect values at time of detection.